Acquire access to data and services to better understand consumers and potential health risks from cannabis-derived products (CDPS)
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40123C00030
- Awardee
-
S-3 Research LLC UEI LELZHK767GF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $358,687
Award facts
- Opportunity
-
- FDASOL1263544 Solicitation number
- Contract value 100% obligated
- $358,686.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92130, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | -$73,486 | |
| Other Administrative Action | $73,486 | |
| Exercise an Option | $183,715 | |
| Original award | $174,972 |
About this award
The Food and Drug Administration awarded a definitive firm fixed-price contract valued at $358,686.73 to S-3 Research LLC, a San Diego-based minority-owned small disadvantaged business specializing in data science and machine learning applications. Under this contract, S-3 Research will acquire access to data and services to better understand consumers and potential health risks associated with cannabis-derived products. The contract, awarded on February 10, 2023, with an ultimate completion date of February 12, 2025, was not designated as a set-aside procurement. This engagement aligns with the FDA's ongoing efforts to monitor and regulate cannabis-derived products, an increasingly complex public health matter as the market for such products continues to expand.
S-3 Research LLC brings significant relevant experience to this engagement, having previously supported federal agencies including the FDA and Drug Enforcement Administration in developing sophisticated digital monitoring and data analysis solutions for regulatory and public health challenges. The firm's expertise in leveraging big data analytics, machine learning, and data visualization to address substance use and public health issues positions it well to deliver actionable consumer insights and risk assessments related to cannabis-derived products. This contract represents part of the company's broader portfolio of work supporting federal agencies in understanding emerging public health threats and regulatory risks in evolving product categories.
Quick answers
Who was awarded contract 75F40123C00030?
75F40123C00030 was awarded to S-3 Research LLC by Food and Drug Administration (Department of Health and Human Services) on February 10, 2023.
How much is contract 75F40123C00030 worth?
The government has obligated $358,687 on 75F40123C00030.
Was contract 75F40123C00030 competed?
The extent of competition for 75F40123C00030 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award